NOT-MH-10-029: Notice of Correction to PAR-10-216 Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01)

Notice of Correction to PAR-10-216 Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01)

Notice Number: NOT-MH-10-029

Key Dates
Release Date: August 5, 2010

Issued by
National Institute of Mental Health (NIMH), (http://www.nimh.nih.gov)

Purpose

The purpose of this notice is to correct the Eligibility Information for PAR-10-216. Foreign Institutions/Organizations are NOT eligible to apply under this funding opportunity. However, an application may include a foreign component.

NIH policies concerning grants to foreign (non-U.S.) organizations can be found in the NIH Grants Policy Statement at: http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part12.htm#_Toc54600260.

The following sections of PAR-10-216 are affected by this change

Section I. Funding Opportunity Description – Partnerships – foreign organizations will be permitted as foreign components of a U.S. grant only.

Section III. Eligibility Information - Non-domestic (non-U.S.)Entities (Foreign Organiations) are not permitted. Although foreign institutitions are NOT eligible to apply under this funding opportunity, an application may include a foreign component.

Section IV. Application and Submission Information - The following section, under 2. Content and Form of Application Submission, is now deleted:

Foreign Organizations [Non-domestic (non-U.S.) Entity]

NIH policies concerning grants to foreign (non-U.S.) organizations can be found in the NIH Grants Policy Statement at: http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part12.htm#_Toc54600260.
Applications from foreign organizations must:

Request budgets in U.S. dollars.
Contain detailed budgets. See NOT-OD-06-096.
Not include charge back of customs and import fees.
Comply with the format specifications, which are based upon a standard U.S. paper size of 8.5” x 11” within each PDF.
If appropriate, funds for up to 8% Facilities and Administrative (F&A) costs (excluding equipment) may be requested. (See NOT-OD-01-028)
Comply with Federal/NIH policies on human subjects, animals, and biohazards.
Comply with Federal/NIH biosafety and biosecurity regulations. See Section VI.2., “Administrative and National Policy Requirements.”

All other aspects of the FOA remain unchanged.

Inquiries

Inquiries regarding this Notice may be directed to:

Jeymohan Joseph, Ph.D.
Division of AIDS Research
National Institute of Mental Health
6001 Executive Boulevard, Room 6219, MSC 9619
Rockville, MD 20892
Telephone: (301) 443-6100
Email: [email protected]